$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Therapeutic inhibitor of vascular smooth muscle cells 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-002/00
출원번호 US-0024885 (2001-12-18)
발명자 / 주소
  • Kunz, Lawrence L.
  • Reno, John M.
출원인 / 주소
  • NeoRx Corporation
대리인 / 주소
    Schwegman, Lundberg, Woessner & Kluth, P.A.
인용정보 피인용 횟수 : 96  인용 특허 : 183

초록

Methods are provided for inhibiting stenosis or restenosis following vascular trauma in a mammalian host, comprising administering to the host a therapeutically effective dosage of a cytostatic agent and/or cytoskeletal inhibitor so as to biologically stent the traumatized vessel. Also provided is a

대표청구항

1. A method to inhibit or reduce vascular remodeling of a traumatized mammalian blood vessel, which method comprises administering to the blood vessel a cytostatic amount of a cytoskeletal inhibitor effective to inhibit or reduce vascular remodeling of the traumatized vessel, wherein the vascular re

이 특허에 인용된 특허 (183)

  1. Schickaneder Helmut (Poing DEX) Lser Roland (Feldafing DEX) Grill Helmut (Vaterstetten DEX), 1,1,2-triphenylbut-1-ene derivatives.
  2. Beck Lee R. (Birmingham AL) Flowers Charles F. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Tanquary Albert C. (Birmingham AL), Active/passive immunization of the internal female reproductive organs.
  3. King Ann C. (Chapel Hill NC), Agents for potentiating the effects of antitumor agents and combating multiple drug resistance.
  4. King Ann C. (Chapel Hill NC), Agents for potentiating the effects of antitumor agents and combating multiple drug resistance.
  5. King Ann C. (Chapel Hill NC), Agents for potentiating the effects of antitumor agents and combating multiple drug resistance.
  6. King Ann C. (Chapel Hill NC), Agents for potentiating the effects of antitumor agents and combating multiple drug resistance.
  7. Hattner Robert S. (Mill Valley CA), Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport.
  8. Hattner Robert S. (Mill Valley CA), Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport.
  9. Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic compositions and methods of use.
  10. Harita ; Kozaburo ; Ajisawa ; Yukiyoshi ; Iizuka ; Kinji ; Kinoshita ; Y ukihiko ; Kamijo ; Tetsuhide ; Kobayashi ; Michihiro, Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same.
  11. Goers John W. F. (Atascadero CA) King Hurley D. (Yardley PA) Lee Chyi (New Brunswick NJ) Coughlin Daniel J. (Plainsboro NJ) Alvarez Vernon L. (Morrisville PA) Rodwell John D. (Yardley PA) McKearn Tho, Antibody-therapeutic agent conjugates.
  12. Cardin Alan D. (Cincinnati OH) Busch Steven J. (West Chester OH) Mano Masayuki (Izumo JPX), Antiproliferative oligomers.
  13. Woods W. T. (R.R. 1-Box 13 Chatham IL 62629), Apparatus and method for angioplasty and for preventing re-stenosis.
  14. Harita Kozaburo (Hongo JA) Ajisawa Yukiyoshi (Okaya JA) Iizuka Kinji (Matsumoto JA) Kinoshita Yukihiko (Matsumoto JA) Kamijo Tetsuhide (Shiojiri JA) Kobayashi Michihiro (Toyoshina JA), Aromatic carboxylic amide derivatives.
  15. Harita Kozaburo (Osaka JPX) Ajisawa Yukiyoshi (Nagano JPX) Iizuka Kinji (Nagano JPX) Kinoshita Yukihiko (Nagano JPX) Kamijo Tetsuhide (Nagano JPX) Kobayashi Michihiro (Nagano JPX), Aromatic carboxylic amide derivatives.
  16. Milius Richard A. (Boston MA) Lambrecht Richard M. (Quogue NY) Bloomer William D. (Wilton CT), Astatinated organic compounds.
  17. Schroeder Daniel (Higganum CT) Lam Kin S. (Cheshire CT) Mattei Jacqueline (East Haven CT) Hesler Grace A. (Branford CT), BMY-41950 antitumor antibiotic.
  18. Schroeder Daniel (Higganum CT) Lam Kin S. (Cheshire CT) Mattei Jacqueline (East Haven CT) Hesler Grace A. (Branford CT), BMY-41950 antitumor antibiotic.
  19. Shaffer Maureen A. (Miami FL) Leone James E. (Miami FL), Balloon catheter for delivering therapeutic agents.
  20. Stack Richard S. (Chapel Hill NC) Clark Howard G. (Durham NC) Walker William F. (Holcomb NY) McElhaney James H. (Durham NC), Bioabsorbable stent and method of making the same.
  21. Wong Vernon G. (Rockville MD), Biodegradable ocular implants.
  22. Slepian Marvin J. (Cleveland Heights OH) Schindler Anton (Durham NC), Biodegradable polymeric endoluminal sealing process.
  23. Narciso ; Jr. Hugh L. (Santa Barbara CA), Biogenic implant for drug delivery and method.
  24. Bell Eugene (Dedham MA), Bone-equivalent and method for preparation thereof.
  25. Barath Peter (West Hollywood CA) Denes Ferenc (Budapest HUX), Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to.
  26. Barath Peter (West Hollywood CA) Denes Ferenc (Budapest HUX), Catheter device for intramural delivery of therapeutic agents.
  27. Markaverich Barry M. (The Woodlands TX) Clark James H. (Houston TX) Gregory Rebecca (Houston TX) Alejandro Mary (Houston TX) Middleditch Brian S. (Houston TX) Johnson Gregory A. (Houston TX) Varma Ra, Cell growth inhibitors and methods of treating cancer and cell proliferative diseases.
  28. Shiozawa Akira (Omiya JPX) Inubushi Atsuro (Tokyo JPX) Narita Kazuhisa (Ageo JPX) Sagawa Yukihiro (Yono JPX) Hosono Makoto (Kitamoto JPX) Iida Masashi (Kitamoto JPX), Certain chroman derivatives useful for treating symptoms caused by contraction of smooth muscles, circulatory diseases o.
  29. Flanagan Richard J. (Hudson CAX) Charleson F. Peter (Kirkland CAX), Chelate derivatives of atrial natriuretic factor (ANF).
  30. Purchio Anthony F. (Seattle WA) Madisen Linda (Seattle WA) Webb Nancy (College Station TX), Cloning and expression of transforming growth factor b 상세보기
  • Fearnot Neal E. (West Lafayette IN) Kozma Thomas G. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees William D. (West Lafayette IN), Coated implantable medical device.
  • Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Kozma Thomas G. ; Voorhees ; III William D., Coated implantable medical device.
  • Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Kozma Thomas G. ; Voorhees ; III William D., Coated implantable medical device.
  • Nikolaychik Victor (Mequon WI) Kipshidze Nicholas N. (Bayside WI) Baker John E. (Wauwatosa WI), Coating intraluminal stents.
  • Gerwick William H. (Corvallis OR) Proteau Philip J. (Corvallis OR) Nagle Dale G. (Corvallis OR), Compound exhibiting antiproliferative activity against cells.
  • Casagrande Cesare (Arese ITX) Montanari Stefania (Milan ITX) Santangelo Francesco (Milan ITX), Compounds active on the cardiovascular system.
  • Dowd Patrick F. (Peoria IL) Cole Richard J. (Albany GA) Vesonder Ronald F. (Peoria IL), Control of insects by fungal tremorgenic mycotoxins.
  • Eppstein Deborah A. (Palo Alto CA) Schryver Brian B. (Redwood City CA), Controlled release of macromolecular polypeptides.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK), Cyclopropyl analogs as anti-estrogenic, anti-tumor and female fertility agents.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK), Cyclopropyl analogs as estrogenic and anti-fertility agents.
  • Fildes Francis J. T. (Macclesfield GB2) Hutchinson Francis G. (Macclesfield GB2), Delivery means for biologically active agents.
  • Just Hansjrg (Kreuzkopfsteige 11 D-7800 Freiburg DEX) Solzbach Ulrich (Spechtweg 15 D-7800 Freiburg DEX), Dilatation catheter.
  • Hendrickson Dennis L. (Overland Park KS) Dimmitt Dan C. (Belton MO) Williams Mark S. (Kansas City MO) Skultety Paul F. (Leawood KS) Baltezor Michael J. (Lees Summit MO), Diltiazem formulation.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Avor Kwasi S. (Columbia MO), Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Avor Kwasi S. (Columbia MO), Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents.
  • Shapland James E. (Shoreview MN) Knudson Mark B. (Shoreview MN) Shimada Jin (Falcon Heights MN) Hildebrand Keith R. (Houlton WI), Drug delivery apparatus and method.
  • Choi ; Nam Sok ; Heller ; Jorge, Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates).
  • Dinh Thomas Q. (Minnetonka MN) Tuch Ronald J. (Plymouth MN) Schwartz Robert S. (Rochester MN), Drug eluting stent.
  • Dinh Thomas Q. (Minnetonka MN) Tuch Ronald J. (Plymouth MN) Schwartz Robert S. (Rochester MN), Drug eluting stent.
  • Wallace Sidney (Houston TX) Yang David (Sugarland TX) Wallace Michael (Houston TX), Efficient microcapsule preparation and method of use.
  • Kaufman Robert J. (University City MO) Richard Thomas J. (University City MO), Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use.
  • Morgan ; Jr. Alton C. (Edmonds WA) Woodhouse Clive S. (Seattle WA) McIntyre Robert F. (Seattle WA), Enhanced production of antibodies utilizing insolubilized immune complexes.
  • Sabel Bernhard A. (Kreuzberg 6 8011 Egmating MA DEX) Freese Andrew (115 Whitcomb Ave. Jamaica Plain MA 02130), Extended drug delivery of small, water-soluble molecules.
  • Hamlin Robert N. (Stillwater MN) Shockey Rick L. (Eagan MN) Tassel Robert A. V. (Excelsior MN), Fiber tip atherectomy catheter.
  • Brandley Brian K. (Alameda CA) Lam Lun H. (Cupertino CA) Laine Roger A. (Alameda CA), Heparin fragments as inhibitors of smooth muscle cell proliferation.
  • Yang David J. (Sugarland TX) Wallace Sidney (Houston TX), High affinity halogenated-tamoxifen derivatives and uses thereof.
  • Yang David J. (Sugarland TX) Wallace Sidney (Houston TX), High affinity tamoxifen derivatives and uses thereof.
  • Ito Ralph K. (Quincy MA) LoGerfo Frank W. (Belmont MA), Hirudin-coated biocompatible substance.
  • Sonnenschein Carlos (Boston MA) Soto Ana M. (Boston MA), In-vitro methods for identifying compositions which are agonists and antagonists of estrogens.
  • Kleinschroth Jrgen (Denzlingen DEX) Hartenstein Johannes (Stegen-Wittental DEX) Schchtele Christoph (Freiburg DEX) Rudolph Claus (Vrstetten DEX), Indolocarbazoles and the use thereof.
  • Clarke Richard H. (Scituate MA), Inhibition of restenosis by ultraviolet radiation.
  • Deckelbaum Lawrence I. (Woodbridge CT) Gasparro Francis P. (Hamden CT) Sumpio Bauer K. (New Haven CT), Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light.
  • Clader John W. (Cranford NJ) Davis Harry R. (Berkeley Heights NJ) Mullins Deborra (New York NY) Rosenblum Stuart (West Orange NJ) Weinstein Jay (Upper Montclair NJ), Inhibitors of platelet-derived growth factor.
  • Fischell Robert E. (14600 Viburnum Dr. Dayton MD 21036) Fischell Tim A. (1018 Chancery La. Nashville TN 37215) Fischell David R. (71 Riverlawn Dr. Fair Haven NJ 07704), Integrated catheter system for balloon angioplasty and stent delivery.
  • Fischell Robert E. (Dayton MD) Fischell Tim A. (Los Altos CA), Intra-arterial stent with the capability to inhibit intimal hyperplasia.
  • Shockey Rick L. (Eagan MN) Van Tassel Robert A. (Excelsior MN), Intravascular drug delivery dilatation catheter.
  • Berg Eric P. (Plymouth MN) Tuch Ronald J. (Plymouth MN) Dror Michael (Edina MN) Wolff Rodney G. (Minnetonka Beach MN), Intravascular stent and method.
  • Berg Eric P. ; Tuch Ronald J. ; Dror Michael ; Wolff Rodney G., Intravascular stent and method.
  • Tuch Ronald J. (Plymouth MN), Intravascular stent and method.
  • Tuch Ronald J. (Plymouth MN), Intravascular stent and method.
  • Tuch Ronald J., Intravasoular stent and method.
  • McCague Raymond (Reigate GB2), Iodotamoxifen derivatives and use for estrogen receptor-positive breast cancer detection and therapy.
  • Miyazono Kohei (Uppsala SEX) Heldin Carl-Henrik (Uppsala SEX) Olofsson Anders (Uppsala SEX), Isolated, large latent complexes of TGF-bb 상세보기
  • Miyazono Kohei (Uppsala SEX) Heldin Carl-Henrik (Uppsala SEX) Olofsson Anders (Uppsala SEX), Isolated, large latent complexes of TGF-bb 상세보기
  • Kauffman Raymond F. (11420 Saint Andrews La. Carmel IN 46032) Singh Jai P. (13774 Hill Crest Ct. Carmel IN 46032), Local delivery of dipyridamole for the treatment of proliferative diseases.
  • Charmot Dominique (Paris FRX) Vidil Christine (Paris FRX), Magnetizable composite microspheres of hydrophobic crosslinked polymer, process for preparing them and their application.
  • Benita Simon (Jerusalem ILX) Levy Menashe (Jerusalem ILX), Medicinal emulsions.
  • Fritzberg Alan R. (Edmonds WA) Kasina Sudhakar (Kirkland WA) Srinivasan Ananthachari (Kirkland WA) Wilbur Daniel S. (Edmonds WA), Metal radionuclide labeled proteins for diagnosis and therapy.
  • Reichert Paul (Montville NJ) McNemar Charles (Basking Ridge NJ) Nagabhushan Nagamani (Parsippany NJ) Nagabhushan Tattanahalli L. (Parsippany NJ) Tindall Stephen (Madison NJ) Hruza Alan (Hackettstown , Metal-interferon-alpha crystals.
  • Slepian Marvin J. (Cleveland Heights OH), Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens.
  • Mnsson Per (Sollentuna SEX) Rolfsen Wenche (Upsala SEX) Wickstrom Kerstin (Upsala SEX), Method and means for inhibiting posterior capsule opacification.
  • Spears J. Richard (Winchester MA) Bourgelais Donna (Malden MA), Method for angioplasty.
  • Tuch Ronald J., Method for delivering a therapeutic substance to a body lumen.
  • March Keith L. (Carmel IN) Hathaway David R. (Indianapolis IN) Wilensky Robert L. (Indianapolis IN), Method for delivery of smooth muscle cell inhibitors.
  • Spears J. Richard (Boston MA), Method for diagnosis of atherosclerosis.
  • Crissman Harry A. (Los Alamos NM) Gadbois Donna M. (Los Alamos NM) Tobey Robert A. (Los Alamos NM) Bradbury E. Morton (Santa Fe NM), Method for distinguishing normal and transformed cells using G1 kinase inhibitors.
  • Ondetti Miguel A. (Princeton NJ) Aberg A. K. Gunnar (Lawrenceville NJ) Ferrer Patricia (Pennington NJ), Method for preventing onset of restenosis after angioplasty employing an ace inhibitor.
  • McGovern Mark E. (Philadelphia PA) Ondetti Miguel A. (Princeton NJ) Pan Henry Y. (Princeton Junction NJ), Method for preventing onset of restenosis after angioplasty employing pravastatin.
  • Dinh Thomas Q. (Minnetonka MN) Dror Michael (Edina MN) Schwartz Robert S. (Rochester MN), Method for preventing restenosis.
  • March Keith L. (Carmel IN) Hathaway David R. (Indianapolis IN) Wilensky Robert L. (Indianapolis IN) Patton Brian L. (Thorntown IN), Method for preventing restenosis following reconfiguration of body vessels.
  • Tamai Hideo (Moriyama JPX) Ueda Kinzo (Kusatsu JPX) Hsu Yung-sheng (Moriyama JPX), Method for the inhibition of restenosis associated with coronary intervention.
  • Wolinsky Harvey (175 Riverside Dr. New York NY 10024), Method for the prevention of restenosis.
  • Stolle Ralph J. (Oregonia OH) Beck Lee R. (Birmingham AL), Method for treating disorders of the vascular and pulmonary systems.
  • Hupe Donald (Ann Arbor MI) Keiser Joan A. (Ann Arbor MI), Method for treating vascular proliferative disorders following balloon angioplasty.
  • Greenwald James E. (St. Louis MO), Method for treatment of arterial stenosis.
  • Fischbarg Jorge (New York NY) Liebovitch Larry S. (Long Island City NY) Koniarek Jan P. (Briarcliff Manor NY), Method of inhibiting osmotic water flow.
  • Harker Laurence A. (San Diego CA) Hanson Stephen R. (Encinitas CA), Method of inhibiting platelet dependent arterial thrombosis.
  • Dinh Thomas Q. (Minnetonka MN) Tuch Ronald J. (Plymouth MN) Schwartz Robert S. (Rochester MN), Method of making a drug eluting stent.
  • Dinh Thomas Q. (Minnetonka MN) Dror Michael (Edina MN) Schwartz Robert S. (Rochester MN), Method of making an intraluminal stent.
  • Kinsella James L. (Baltimore MD) Sollott Steven J. (Baltimore MD), Method of treating atherosclerosis or restenosis using microtubule stabilizing agent.
  • Gregory Clare R. (Davis CA) Morris Randall E. (Los Altos CA), Method of treating hyperproliferative vascular disease.
  • Mitchell Robert D. (Doylestown PA) Skwish Stephen (Mercer NJ), Method of treating hyperproliferative vascular disease.
  • Morris Randall E. (Los Altos CA) Gregory Clare R. (Menlo Park CA), Method of treating hyperproliferative vascular disease.
  • Morris Randall E. (Stanford CA) Bartlett Robert R. (Darmstadt DEX), Method of treating hyperproliferative vascular disease.
  • Morris Randall Ellis (Los Altos CA) Gregory Clare Robert (Menlo Park CA), Method of treating hyperproliferative vascular disease.
  • Morris Randall Ellis (Los Altos CA) Gregory Clare Robert (Menlo Park CA), Method of treating hyperproliferative vascular disease with rapamycin and mycophenolic acid.
  • Morris Randall E. (Los Altos CA) Gregory Clare R. (Menlo Park CA), Method of treating restenosis with rapamycin.
  • Spears James R. (Boston MA), Method of treatment of atherosclerosis and a balloon catheter for same.
  • Daddona Peter E. (West Chester PA) Berger Harvey J. (Devon PA) McEver Rodger P. (Oklahoma City OK), Methods for imaging atherosclerotic plaque.
  • Fontana Steven A. (Martinsville IN), Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives.
  • Black Larry J. (Indianapolis IN) Cullinan George J. (Trafalgar IN), Methods for inhibiting bone loss.
  • Bryant Henry U. (Indianapolis IN) Dodge Jeffrey A. (Indianapolis IN), Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and u.
  • Dodge Jeffrey A. (Indianapolis IN) Sato Masahiko (Carmel IN), Methods of inhibiting vascular restenosis.
  • Purchio Anthony F. (Seattle WA) Madisen Linda (Seattle WA) Merwin June R. (Clinton CT), Methods using novel chimeric transforming growth factor-bb 상세보기
  • Scher Herbert B. (Moraga CA) Rodson Marius (El Cerrito CA), Microcapsules.
  • Wolf Peter A. (100 Stevens Ave. Valhalla NY 10595) Havekotte Margaret J. (74 Byram Terrace Dr. Greenwich CT 06830), Microemulsions of oil in water and alcohol.
  • Lee Haibang (Daejun-si KRX) Yuk Soonhong (Daejun-si KRX), Microencapsulation for controlled oral drug delivery system.
  • Kent John S. (Cupertino CA) Lewis Danny H. (Birmingham AL) Sanders Lynda M. (Palo Alto CA) Tice Thomas R. (Birmingham AL), Microencapsulation of water soluble active polypeptides.
  • Tice Thomas R. (Helena AL) Lewis Danny H. (Gardendale AL), Microencapsulation process.
  • Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL), Microencapsulation process and products therefrom.
  • Vidal Juan C. (Boston MA), Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent.
  • Prather Randall S. (Madison WI) Barnes Frank (Madison WI) Robl James (Belchertown MA) First Neal L. (Madison WI) Simmon Vincent F. (Potomac MD), Multiplying bovine embryos.
  • Conrad H. Edward (Alameda CA) Guo Yuchuan (Alameda CA), Non-anticoagulant heparin derivatives.
  • Lioubin Mario N. (Bellevue WA) Brown Thomas J. (Seattle WA) Purchio Anthony F. (Seattle WA), Normal human growth regulatory receptor for TGF-b 상세보기
  • Derynk Rik M. A. (So. San Francisco CA) Goeddel David V. (Forestview CA), Nucleic acid encoding TGF-b 상세보기
  • Marquardt Hans (Mercer Island WA) Zarling Joyce M. (Seattle WA) Shoyab Mohammed (Seattle WA) Hanson Marcia B. (Seattle WA) Lioubin Mario N. (Bellevue WA) Brown Thomas J. (Seattle WA) Ikeda Tatsuhiko , Oncostatin M and novel compositions having anti-neoplastic activity.
  • Fretto Larry J. (Sausalito CA), PDGF receptor blocking peptides.
  • Demopoulos Harry B. (Scarsdale NY), Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis fol.
  • Bisaccia Emil (4 Sunnybrook Rd. Basking Ridge NJ 07920) Klainer Albert S. (315 W. 70th St. New York NY 10023), Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty.
  • Matsuda, Yuzuru; Iwahashi, Kazuyuki; Iida, Takao; Hirayama, Noriaki; Asano, Kozo; Shuto, Katsuichi; Yamada, Koji; Shirahata, Kunikatsu; Kase, Hiroshi, Physiologically active substance K-252, process for producing same and pharmaceutical composition containing same.
  • Novak Sarah T. A. (Cary NC) Soll Richard M. (Lawrenceville NJ) Ellingboe John W. (Princeton NJ) Nguyen Thomas T. (Philadelphia PA), Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation.
  • Racchini Joel R. (Edina MN) Shapland James E. (Shoreview MN) Knudson Mark B. (Shoreview MN) Shimada Jin (Falcon Heights MN) Hildebrand Keith R. (Houlton WI), Porous balloon for selective dilatation and drug delivery.
  • Stossel Thomas P. (Belmont MA) Hartwig John H. (Jamaica Plain MA) Janmey Paul A. (Arlington MA), Preservation of blood platelets.
  • Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Weissberg Peter L.,GB2, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Bindschaedler Christian (4 route de Malagny CH 1294 Genthold CHX) Gurny Robert (7 rue Calvin CH 1204 Geneva CHX) Doelker Eric (24 avenue Dumas CH 1206 Geneva CHX), Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powd.
  • Platz Robert M. (Half Moon Bay CA) Ip Anna (Moorpark CA) Whitham Clyde L. (Montara CA), Process for preparing micronized polypeptide drugs.
  • O\Toole Michael P. (Norwalk CT), Process for producing small polymer phase droplet microemulsions by multistep aqueous phase addition.
  • Murakata Chikara (Hachioji JPX) Takiguchi Toshimitsu (Gotenba JPX) Katsumata Shigeo (Mishima JPX) Mihara Akira (Machida JPX) Takahashi Keiichi (Susono JPX) Saito Hiromitsu (Mishima JPX) Akinaga Shiro, Process for producing staurosporine derivatives.
  • Burch Ronald M. (Silver Spring MD) Patch Raymond J. (Baltimore MD) Shearer Barry G. (Baltimore MD) Perumattam John J. (Baltimore MD), Protein kinase C modulators.
  • Dake Michael D. (1915 Mandeville Canyon Rd. Los Angeles CA 90049) Hedger Bruce (16220 Gundry Ave. Paramount CA 90723) Oesterle Stephen (101 Burlingame Ave. Los Angeles CA 90049), Radioactive catheter.
  • Cox Edward T. (Foster City CA) Mather Jennie P. (Millbrae CA) Sliwkowski Mary B. (San Carlos CA) Woodruff Teresa K. (Millbrae CA), Receptor polypeptides and their production and uses.
  • Dror Michael (Edina MN) Trescony Paul (Robbinsdale MN), Releasable coatings on balloon catheters.
  • Niikura Kazuaki (Ibaraki JPX) Nakajima Yoshimitsu (Ibaraki JPX) Notsu Yoshitada (Ibaraki JPX) Ono Ryuji (Ibaraki JPX) Nakayama Osamu (Ibaraki JPX), Remedies for bone diseases.
  • Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Osborne Thomas A. ; Kozma Thomas G. ; Roberts Joseph W. ; Voorhees ; III William D., Silver implantable medical device.
  • Wheeler Jeffery J. (Vancouver CAX) Bally Marcel B. (Bowen Island CAX), Stable microemulsions for hydrophobic compound delivery.
  • Caravatti Giorgio (Allschwil CHX) Fredenhagen Andreas (Basel CHX), Staurosporine derivatives substituted at methylamino nitrogen.
  • Williams Michael S. (Cupertino CA), Stent capable of attachment within a body lumen.
  • Ichijo Hidenori (Upsala SEX) Miyazono Kohei (Upsala SEX) Rnnstrand Lars (Upsala SEX) Hellman Ulf (Upsala SEX) Wernstedt Christer (Upsala SEX) Heldin Carl-Henrik (Upsala SEX), Substantially pure receptor like TGF-b 상세보기
  • Conrad H. Edward (Alameda CA) Fugedi Peter (Alameda CA) Brandley Brian K. (Alameda CA) Lam Lun H. (Cupertino CA) Laine Roger A. (Alameda CA), Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation.
  • Liversidge Gary G. (West Chester PA) Cundy Kenneth C. (Pottstown PA) Bishop John F. (Rochester NY) Czekai David A. (Honeoye Falls NY), Surface modified drug nanoparticles.
  • Purchio Anthony F. (Seattle WA) Skonier John E. (Seattle WA) Neubauer Michael G. (Seattle WA), TGF-b 상세보기
  • Srinivasan Ananthachari (Kirkland WA) Brixner Diana I. (Lynnwood WA) Vrudhula Vivekananda M. (Edmonds WA), Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages.
  • Kunz Lawrence L., Therapeutic inhibitor of vascular smooth muscle cells.
  • Kunz Lawrence L., Therapeutic inhibitor of vascular smooth muscle cells.
  • Kunz Lawrence L. ; Klein Richard A. ; Reno John M., Therapeutic inhibitor of vascular smooth muscle cells.
  • Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Weissberg Peter L.,GB2 ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  • Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  • Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  • Kunz Lawrence L. ; Reno John M., Therapeutic inhibitor of vascular smooth muscle cells.
  • Abiuso Christopher L. (Miami FL) Leone James E. (Miami FL), Therapeutic porous balloon catheter.
  • Stossel Thomas P. (Belmont MA) Lind Stuart E. (Belmont MA) Janmey Paul A. (Belmont MA), Therapeutic uses of actin-binding compounds.
  • Baldus Berthold (Berlin DEX) Maass Bernhard (Berlin DEX) Mller Bernd (Berlin DEX) Witt Werner (Berlin DEX), Thrombosis treatment with fibrinolytics and prostacyclins.
  • Bell Eugene (Dedham MA), Tissue-equivalent and method for preparation thereof.
  • Ohlstein Eliot H. (Glenmoore PA), Treatment of athereosclerosis using, carbazolyl-(4)-oxypropanolamine compounds.
  • Leveen Harry H. (321 Confederate Cir. Charleston SC 29407) Leveen Robert F. (312 Lombard St. Philadelphia PA 19147) Leveen Eric G. (141 S. Battery Charleston SC 29401), Treatment of cancer with phlorizin and its derivatives.
  • Trager Seymour F. (14 Sherwood Dr. Plainview NY 11803) Blackburn G. Michael (23 Crimicar La. Sheffield ; S10 4FA GBX), Treatment of glaucoma.
  • Casscells Ward M. (La Jolla CA) Lappi Douglas A. (Del Mar CA) Baird J. Andrew (San Diego CA), Treatment of vascular injury.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Day Billy W. (Newtonville MA), Triarylcyclopropanes as antiestrogens and antitumor agents.
  • Ruenitz Peter C. (Clarke City GA), Triarylethylene carboxylic acids with estrogenic activity.
  • Pavanasasivam Gowsala (Edmonds WA), Trichothecene antibody conjugates.
  • Sivam Gowsala (Edmonds WA), Trichothecene conjugates and methods of use.
  • Nakano Hirofumi (Machida JPX) Takahashi Isami (Machida MA JPX) Tamaoki Tatsuya (Brooklin MA) Tomita Fusao (Machida JPX) Kawamoto Isao (Hiratsuka JPX) Asano Kozo (Machida JPX) Morimoto Makoto (Nagaizu, UCN-01 and process for production thereof.
  • Fischell Robert E. (Dayton MD) Fischell Tim A. (Los Altos CA), Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct.
  • Hansson Gran (Dr Linds gata 6 S-413 25 Gteborg SEX) Holm Jan (nggardsplatsen 8 S-413 19 Gteborg SEX) Jonasson Lena (Grna gatan 8 S0575 33Eksj SEX), Use of gamma-interferon for the treatment of vascular stenosis.
  • Falk Rudolf Edgar,CAX ; Ascuali Samuel Simon,CAX ; Turley Eva Anne,CAX, Use of hyaluronic acid and forms to prevent arterial restenosis.
  • Falk Rudolf Edgar,CAX ; Asculai Samuel Simon,CAX ; Turley Eva Anne,CAX, Use of hyaluronic acid and forms to prevent arterial restenosis.
  • Na George C. (Fort Washington PA) Rajagopalan Natarajan (Phoenixville PA), Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization.
  • Brahn Ernest (Encino CA), Use of taxol in the treatment of rheumatoid arthritis.
  • Harris Adrian L. (83 Kingston Road Oxford OX2 64J GB3) Kangas Lauri V. M. (Pasantie 3 B 21280 Raisio CT FIX) DeGregorio Michael W. (93 Leatherman Trail Hamden CT 06518), Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs.
  • Ohlstein Eliot H. (Glenmoore PA), Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell pr.
  • Yue Tian-Li (Havertown PA) Ohlstein Eliot H. (Glenmoore PA) Feuerstein Giora Z. (Wynnewood PA), Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and prolifer.
  • Lewis Jerome M. (Newton MA) Menz Edward T. (Quincy MA) Kenny Francis E. (Watertown MA) Groman Ernest V. (Brookline MA) Josephson Lee (Arlington MA), Vascular magnetic resonance imaging agent comprising nanoparticles.
  • 이 특허를 인용한 특허 (96)

    1. Tijsma,Edze Jan; Driessen Levels,Anita; Hendriks,Marc, Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function.
    2. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
    3. Klein, Kyle; Murase, Katsuyuki; Wan, Jinping; Davalian, Dariush, Bioactive agent-loaded targeting micelles.
    4. Roth, Noah M.; Kondabatni, Kishore; Karnati, Chandana; Brodbeck, William, Biodegradable device.
    5. Concagh, Danny; Cheng You, Chang; Zugates, Greg, Bioresorbable thermoset polyester/urethane elastomers.
    6. Furst, Joseph G.; Brodbeck, William G., Coated medical device.
    7. Michal, Eugene T.; Basu, Shubhayu; Sheehy, Alexander J.; Spinale, Francis G.; Mukherjee, Rupak, Composition for modifying myocardial infarction expansion.
    8. Claude, Charles D.; Kawula, Paul J.; Hossainy, Syed Faiyaz Ahmed; Tran, Kimchi, Device and method for combining a treatment agent and a gel.
    9. Savage, Douglas R.; Shulze, John E.; Betts, Ronald E.; Fariabi, Sepehr; Su, Shih-Horng, Drug delivery endovascular stent and method of use.
    10. Palasis, Maria; You, Changcheng; Concagh, Daniel; Core, Lee; Ho, Kirchel; Sharma, Upma; Zugates, Gregory T., Drug eluting medical implant.
    11. Palasis, Maria; You, Changcheng; Concagh, Danny; Core, Lee; Ho, Kicherl; Sharma, Upma; Zugates, Gregory T., Drug eluting medical implant.
    12. Wang, Lixiao, Drug releasing coatings for balloon catheters.
    13. Wang, Lixiao, Drug releasing coatings for balloon catheters.
    14. Wang, Lixiao, Drug releasing coatings for balloon catheters.
    15. Wang, Lixiao, Drug releasing coatings for medical devices.
    16. Wang, Lixiao, Drug releasing coatings for medical devices.
    17. Wang, Lixiao, Drug releasing coatings for medical devices.
    18. Wang, Lixiao, Drug releasing coatings for medical devices.
    19. Savage, Douglas R.; Betts, Ronald E., Drug-delivery endovascular stent and method for treating restenosis.
    20. Savage, Douglas R.; Betts, Ronald E., Drug-delivery endovascular stent and method for treating restenosis.
    21. Shulze, John E.; Betts, Ronald E.; Savage, Douglas R., Drug-delivery endovascular stent and method for treating restenosis.
    22. Shulze, John E.; Betts, Ronald E.; Savage, Douglas R., Drug-delivery endovascular stent and method for treating restenosis.
    23. Shulze, John E.; Betts, Ronald E.; Savage, Douglas R., Drug-delivery endovascular stent and method for treating restenosis.
    24. Shulze, John E.; Betts, Ronald E.; Savage, Douglas R., Drug-delivery endovascular stent and method for treating restenosis.
    25. Betts, Ronald E.; Savage, Douglas R., Drug-delivery endovascular stent and method of forming the same.
    26. Shulze, John E.; Betts, Ronald E.; Savage, Douglas R., Drug-delivery endovascular stent and method of forming the same.
    27. Shulze, John E.; Betts, Ronald E.; Savage, Douglas R., Drug-delivery endovascular stent and method of forming the same.
    28. Savage, Douglas R.; Shulze, John E.; Betts, Ronald E.; Fariabi, Sepehr; Su, Shih-Horng, Drug-delivery endovascular stent and method of use.
    29. Shanley, John F., Expandable medical device for delivery of beneficial agent.
    30. Shanley, John F., Expandable medical device for delivery of beneficial agent.
    31. Shanley, John F., Expandable medical device for delivery of beneficial agent.
    32. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
    33. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
    34. Shanley,John F.; Eigler,Neal L.; Park,Kinam; Edelman,Elazer R., Expandable medical device for delivery of beneficial agent.
    35. Shanley, John F., Expandable medical device with S-shaped bridging elements.
    36. Shanley, John F., Expandable medical device with beneficial agent concentration gradient.
    37. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
    38. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
    39. Shanley, John F., Expandable medical device with ductile hinges.
    40. Shanley, John F., Expandable medical device with ductile hinges.
    41. Ehrenreich, Kevin J.; Newhauser, Richard R.; von Oepen, Randolf; Stankus, John, Expandable member formed of a fibrous matrix for intraluminal drug delivery.
    42. Ehrenreich, Kevin J.; Newhauser, Richard R.; von Oepen, Randolf; Stankus, John, Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery.
    43. Von Oepen, Randolf; Stankus, John; Stamberg, Barbara; Yribarren, Travis R.; Newhauser, Richard R., Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery.
    44. Claude, Charles; Kwok, Connie; Michal, Gene; Qu, Jihong; Liao, Sophia, Hydrogel bioscaffoldings and biomedical device coatings.
    45. Shanley, John F.; Parker, Theodore L.; Park, Kinam, Implantable medical device with beneficial agent concentration gradient.
    46. Shanley,John F.; Parker,Theodore L., Implantable medical device with drug filled holes.
    47. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    48. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    49. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    50. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    51. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    52. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    53. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    54. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    55. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    56. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    57. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    58. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    59. Michal, Eugene T.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
    60. Wang, Lixiao, Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent.
    61. Wang, Lixiao, Medical device rapid drug releasing coatings comprising oils, fatty acids and/or lipids.
    62. Kutryk, Michael J. B.; Cottone, Jr., Robert J.; Rowland, Stephen M., Medical device with coating for capturing genetically-altered cells and methods for using same.
    63. Busold, Rany; You, Chang cheng; Concagh, Daniel; Core, Lee; Ho, Kicherl; Palasis, Maria; Sharma, Upma; Zugates, Greg, Medical implant.
    64. Busold, Rany; You, Changcheng; Concagh, Daniel; Core, Lee; Ho, Kicherl; Palasis, Maria; Sharma, Upma; Zugates, Greg, Medical implant.
    65. Palasis, Maria; Cheng You, Chang; Concagh, Daniel; Core, Lee; Ho, Kicherl; Sharma, Upma; Zugates, Greg, Medical implant.
    66. Palasis, Maria; You, Changcheng; Concagh, Daniel; Core, Lee; Ho, Kicherl; Sharma, Upma; Zugates, Gregory T., Medical implants.
    67. Furst, Joseph G.; Patel, Udayan; Buckman, Raymond, Metal alloys for medical devices.
    68. Furst,Joseph G.; Patel,Udayan; Buckman, Jr.,Raymond W., Metal alloys for medical devices.
    69. Buckman, Jr., Raymond W.; Patel, Udayan; Furst, Joseph, Method for forming a tubular medical device.
    70. Rossi, Mara, Method for the quantitative determination of poloxamers.
    71. Basu, Shubhayu; Chan, Gregory Waimong, Methods and compositions for treating post-cardial infarction damage.
    72. Basu, Shubhayu; Chan, Gregory Waimong; Min, Sungwoo, Methods and compositions for treating post-cardial infarction damage.
    73. Michal, Eugene T.; Mandrusov, Evgenia; Claude, Charles D.; Ding, Ni; Simhambhatla, Murthy; Hossainy, Syed Faiyaz Ahmed; Sridharan, Srinivasan; Consigny, Paul, Methods and compositions to treat myocardial conditions.
    74. Michal, Eugene T.; Mandrusov, Evgenia; Claude, Charles D.; Ding, Ni; Simhambhatla, Murthy; Hossainy, Syed Faiyez Ahmed; Sridharan, Srinivasan; Consigny, Paul, Methods and compositions to treat myocardial conditions.
    75. Michal, Eugene T.; Ross, Jeffrey, Methods and compositions to treat myocardial conditions.
    76. Michal, Eugene T.; Basu, Shubhayu; Sheehy, Alexander J.; Spinale, Francis G.; Mukherjee, Rupak, Methods of modifying myocardial infarction expansion.
    77. Michal, Gene; Basu, Shubhayu, Modified two-component gelation systems, methods of use and methods of manufacture.
    78. Koullick, Edouard; Hendriks, Marc; Bertrand, William, Occlusion resistant hydrocephalic shunt.
    79. Douk, Nareak; Busold, Rany; Core, Lee; Ho, Kicherl; Le, My, Polymeric implant delivery system.
    80. Ruane, Patrick H., Post-processing of a medical device to control morphology and mechanical properties.
    81. Hossainy, Syed; Ludwig, Florian Niklas; Pacetti, Stephen; Consigny, Paul; El-Nounou, Fozan; Glauser, Thierry; DesNoyer, Jessica, Pro-healing agent formulation compositions, methods and treatments.
    82. Furst, Joseph G.; Patel, Udayan; Buckman, Jr., Raymond W., Process for forming an improved metal alloy stent.
    83. Cottone, Jr., Robert John; Yoklavich, Margaret; Parker, Sherry, Progenitor endothelial cell capturing with a drug eluting implantable medical device.
    84. Furst, Joseph G., Stent coating.
    85. Ehrenreich, Kevin J.; Newhauser, Richard; von Oepen, Randolf; Stankus, John, Stent delivery system having a fibrous matrix covering with improved stent retention.
    86. Ehrenreich, Kevin J.; Newhauser, Richard; von Oepen, Randolf; Stankus, John J., Stent delivery system having a fibrous matrix covering with improved stent retention.
    87. Alt, Eckhard, Stent device and method.
    88. Shanley,John F., Stent wall structure.
    89. Shanley,John F., Stent wall structure.
    90. Furst, Joseph G., Sutures and surgical staples for anastamoses, wound closures, and surgical closures.
    91. Shanley, John F.; Parker, Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
    92. Shanley,John F.; Parker,Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
    93. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
    94. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
    95. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
    96. Furst,Joseph G.; Brodbeck,William, Vascular grafts with amphiphilic block copolymer coatings.

    문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로